As of Sep 23
| -0.1199 / -9.75%|
The 4 analysts offering 12-month price forecasts for Xtant Medical Holdings Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +350.41% increase from the last price of 1.11.
The current consensus among 4 polled investment analysts is to Buy stock in Xtant Medical Holdings Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.